Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FCA fines Monzo £21.1m for financial crime control failures

(Sharecast News) - Monzo Bank was fined £21.1m by the Financial Conduct Authority on Tuesday, for serious failures in its financial crime controls between October 2018 and August 2020. The regulator found that Monzo's systems and processes did not keep pace with its rapid customer growth and product expansion, leaving the bank exposed to financial crime risks.

According to the FCA, Monzo failed to design and maintain effective systems for customer onboarding, risk assessments, and transaction monitoring.

The deficiencies prompted the watchdog to commission an independent review of the challenger bank's financial crime framework in August 2020.

It also imposed a restriction on Monzo in 2020, barring it from opening new accounts for high-risk customers.

Despite that, the bank continued to onboard over 34,000 such customers up to June 2022, in breach of the requirement.

"Monzo fell far short of what we, and society, expect," said Therese Chambers, the FCA's joint executive director of enforcement and market oversight.

"Monzo onboarded customers on the basis of limited, and in some cases, obviously implausible information - such as customers using well known London landmarks as an address.

"This illustrates how lacking Monzo's financial crime controls were."

Monzo had since completed a financial crime change programme to overhaul and strengthen its control framework in line with recommendations from the independent review.

The fine was the latest in a series of enforcement actions by the FCA, which has penalised 10 banks over financial crime failings in the past four years.

Financial crime remained a supervisory priority for the regulator in its 2024 strategy for retail banks.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.